Pictet Asset Management (Switzerland)’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,200	Closed	-$51K	–	2000
2022 Q4	$51K	Buy	+12,200	New	+$46.2K	﹤0.01%	1960
2022 Q2	–	Sell	-328,376	Closed	-$5.33M	–	1636
2022 Q1	$5.33M	Sell	328,376 -695,825	-68%	-$17.8M	0.01%	802
2021 Q4	$48.5M	Buy	1,024,201 +93,184	+10%	+$5.59M	0.05%	343
2021 Q3	$67.5M	Buy	+931,017	New	+$67.3M	0.07%	286

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s NBP Position: Q1 2023 in Review

Pictet Asset Management (Switzerland) sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2023, closing a stake of 12,200 shares — an estimated $51K sold.

Pictet Asset Management (Switzerland) first reported a position in NBP in Q3 2021 and held it in 4 quarters. The position peaked at $67.5M in Q3 2021. 53 funds tracked by Wall St. Rank hold NBP as of Q1 2023.

Pictet Asset Management (Switzerland) reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2023 after selling out during the quarter.
Pictet Asset Management (Switzerland) sold 12,200 NovaBridge Biosciences American Depositary Shares shares in Q1 2023, an estimated $51K.
Pictet Asset Management (Switzerland) first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2021 and held it in 4 quarters.
Pictet Asset Management (Switzerland)'s NovaBridge Biosciences American Depositary Shares position peaked at $67.5M in Q3 2021.
53 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q1 2023, filed 10 May 2023.